Page last updated: 2024-12-05

tetradecyltrimethylammonium

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Tetradecyltrimethylammonium bromide (TTAB) is a cationic surfactant with a long alkyl chain, exhibiting both hydrophobic and hydrophilic properties. It is synthesized through the quaternization of tetradecylamine with trimethylamine. TTAB finds applications in various fields, including:
- **Biochemistry:** It disrupts cell membranes and acts as a cell lysis agent, aiding in the extraction of intracellular components.
- **Cosmetics:** TTAB is a common ingredient in shampoos and conditioners, providing conditioning and antistatic effects.
- **Medicine:** It exhibits antimicrobial activity, making it useful in antiseptic solutions and disinfectants.
- **Material Science:** TTAB is used in the synthesis of nanoparticles and nanomaterials, facilitating the formation of self-assembled structures.
- **Research:** TTAB is a model system for studying the properties of surfactants, including micelle formation, critical micelle concentration, and surface tension reduction.'

tetradecyltrimethylammonium: cationic surfactant; used to determine thermal stability of DNA; Catrimox-14 is the tradename of the oxalate; Catrimox-14 lyses cells and simultaneously precipitates RNA and was demonstrated useful in isolating RNA from whole blood [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID14251
CHEMBL ID113150
CHEMBL ID1180003
SCHEMBL ID119448
MeSH IDM0054072

Synonyms (27)

Synonym
tetradecyltrimethylammonium
trimethyl(tetradecyl)azanium
FT-0653320
chembl113150
trimethyl-tetradecyl-ammonium; bromide
bdbm50060597
10182-92-0
NCGC00166121-02
y3ir7rct6j ,
unii-y3ir7rct6j
n,n,n-trimethyl-1-tetradecanaminium
einecs 233-454-5
trimethyltetradecylammonium
CHEMBL1180003
AKOS015915095
tetradonium cation
ammonium, trimethyltetradecyl-
myristyltrimethylammonium
tetradonium
tetradonium ion
1-tetradecanaminium, n,n,n-trimethyl-
SCHEMBL119448
GLFDLEXFOHUASB-UHFFFAOYSA-N
n,n,n-trimethyltetradecan-1-aminium
DTXSID9045009
myristyltrimethylammonium; tetradecyltrimethylammonium
Q27294221

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
"Oral bioavailability of a drug molecule requires its effective delivery to the target site."( Drug Partitioning in Micellar Media and Its Implications in Rational Drug Design: Insights with Streptomycin.
Judy, E; Kishore, N; Pagariya, D, 2018
)
0.48

Dosage Studied

ExcerptRelevanceReference
" The dose-response curve of mastoparan-induced histamine release from intact mast cells was shifted to the right by various concentrations of BAC (C14)."( The mechanism of inhibition of alkylamines on the mast-cell peptidergic pathway.
Bronner, C; Fischer, T; Landry, Y; Mousli, M, 1993
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (7)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
LuciferasePhotinus pyralis (common eastern firefly)Potency32.19680.007215.758889.3584AID624030
phosphopantetheinyl transferaseBacillus subtilisPotency11.22020.141337.9142100.0000AID1490
USP1 protein, partialHomo sapiens (human)Potency50.11870.031637.5844354.8130AID504865
huntingtin isoform 2Homo sapiens (human)Potency15.84890.000618.41981,122.0200AID1688
nuclear receptor ROR-gamma isoform 1Mus musculus (house mouse)Potency7.19120.00798.23321,122.0200AID2546; AID2551
gemininHomo sapiens (human)Potency11.88560.004611.374133.4983AID624297
peripheral myelin protein 22Rattus norvegicus (Norway rat)Potency30.61260.005612.367736.1254AID624032; AID624044
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID504749qHTS profiling for inhibitors of Plasmodium falciparum proliferation2011Science (New York, N.Y.), Aug-05, Volume: 333, Issue:6043
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (121)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (4.13)18.7374
1990's22 (18.18)18.2507
2000's54 (44.63)29.6817
2010's37 (30.58)24.3611
2020's3 (2.48)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 32.83

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index32.83 (24.57)
Research Supply Index4.83 (2.92)
Research Growth Index5.10 (4.65)
Search Engine Demand Index42.45 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (32.83)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other124 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]